| Robert M Dermarkarian, MD | |
|
2221 Se Ocean Blvd, Suite 100, Stuart, FL 34996-3341 | |
| (772) 283-4428 | |
| Not Available |
| Full Name | Robert M Dermarkarian |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 43 Years |
| Location | 2221 Se Ocean Blvd, Stuart, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770675530 | NPI | - | NPPES |
| 252713800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME0067824 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Options Home Health | West palm beach, FL | Home health agency |
| Cleveland Clinic Martin North Hospital | Stuart, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary And Internal Medicine Associates Inc | 7315036779 | 3 |
News Archive
GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.
Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award.
National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries-cranberries, blueberries and bilberries. As described in a recent paper, manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools.
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
› Verified 9 days ago
| Entity Name | Pulmonary & Internal Medicine Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013009810 PECOS PAC ID: 7315036779 Enrollment ID: O20071207000707 |
News Archive
GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.
Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award.
National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries-cranberries, blueberries and bilberries. As described in a recent paper, manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools.
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert M Dermarkarian, MD 2221 Se Ocean Blvd, Suite 100, Stuart, FL 34996-3341 Ph: (772) 283-4428 | Robert M Dermarkarian, MD 2221 Se Ocean Blvd, Suite 100, Stuart, FL 34996-3341 Ph: (772) 283-4428 |
News Archive
GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.
Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award.
National Institute of Standards and Technology (NIST) researchers have developed new certified reference materials for measuring amounts of organic acids in dietary supplements formulated with Vaccinium berries-cranberries, blueberries and bilberries. As described in a recent paper, manufacturers and researchers can use this new suite of standard reference materialsTM (SRMs) as quality assurance tools.
Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
› Verified 9 days ago
Dr. Laura Munoz Beringer, M.D., MPH Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 614 Se Central Pkwy, Stuart, FL 34994 Phone: 772-266-0978 Fax: 772-380-4815 | |
Gaurav R Shah, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Se Osceola St, Ste 200, Stuart, FL 34994 Phone: 772-286-1550 Fax: 772-221-0569 | |
Dr. Sajith Foustin Joseph, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave # 2346, Stuart, FL 34994 Phone: 772-287-5200 | |
Dr. Ihsan Yassine, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 Se Monterey Rd Ste 303, Stuart, FL 34994 Phone: 772-288-2400 Fax: 772-419-0143 | |
Priya Vikash Negandhi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Se Hospital Ave, Stuart, FL 34994 Phone: 772-223-5618 Fax: 772-288-5834 | |
Dr. Resham Khilnani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Se Osceola St, Ste 200, Stuart, FL 34994 Phone: 772-286-1550 Fax: 772-221-0569 | |
Dr. Joseph S Gage, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 Se Monterey Commons Blvd, Suite 300, Stuart, FL 34996 Phone: 772-286-9400 Fax: 772-283-3832 |